APO RESEARCH · REPORT
Fish Vaccine
Fish vaccine are vaccine specially used on fish. The culture environment, be it in tanks, cages or ponds, seawater or freshwater, can stress the fish due to high stocking densities, reduced oxygen levels, sub-optimal water quality and high pathogen loads. Therefore, farmed fish, similar to farmed animals, have an increased susceptibility to infectious diseases. Such diseases may be bacterial, viral, fungal or parasitic in origin. These are the immune foundations for immunizing fish against various diseases.
Product & engineering
Understand the product.
Fish vaccine are vaccine specially used on fish. The culture environment, be it in tanks, cages or ponds, seawater or freshwater, can stress the fish due to high stocking densities, reduced oxygen levels, sub-optimal water quality and high pathogen loads. Therefore, farmed fish, similar to farmed animals, have an increased susceptibility to infectious diseases. Such diseases may be bacterial, viral, fungal or parasitic in origin. These are the immune foundations for immunizing fish against various diseases.
Selected research
Market Outlook & Growth Opportunities
Global Fish Vaccine Market Outlook and Growth Opportunities 2026
Market perspective
Fish vaccine are vaccine specially used on fish. The culture environment, be it in tanks, cages or ponds, seawater or freshwater, can stress the fish due to high stocking densities, reduced oxygen levels, sub-optimal water quality and high pathogen loads. Therefore, farmed fish, similar to farmed animals, have an increased susceptibility to infectious diseases. Such diseases may be bacterial, viral, fungal or parasitic in origin. These are the immune foundations for immunizing fish against various diseases.
The industry's leading producers are Zoetis and Merck & Co., Inc., which accounted for 52.92% and 34.85% of revenue in 2019, respectively.
This report provides an overview of the global Fish Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Fish Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Fish Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fish Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.
Fish Vaccine Segment by Company
Zoetis
Merck & Co., Inc.
Tecnovax
Veterquimica S.A.
HIPRA
Anicon Labor GmbH
Fish Vaccine Segment by Type
Injectable Vaccines
Dip Vaccines
Oral Vaccine
Fish Vaccine Segment by Application
Pangasius
Tilapia
Salmon
Seabass
Others
Fish Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Fish Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Fish Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Fish Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Fish Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fish Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fish Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fish Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Fish Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fish Vaccine industry.
Chapter 3: Detailed analysis of Fish Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Fish Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Fish Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Injectable Vaccines
- Dip Vaccines
- Oral Vaccine
Applications
- Pangasius
- Tilapia
- Salmon
- Seabass
- Others
Companies covered
- Zoetis
- Merck & Co., Inc.
- Tecnovax
- Veterquimica S.A.
- HIPRA
- Anicon Labor GmbH
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Fish Vaccine Sales Value (2021-2032)
- 1.2.2 Global Fish Vaccine Sales Volume (2021-2032)
- 1.2.3 Global Fish Vaccine Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Fish Vaccine Market Dynamics
- 2.1 Fish Vaccine Industry Trends
- 2.2 Fish Vaccine Industry Drivers
- 2.3 Fish Vaccine Industry Opportunities and Challenges
- 2.4 Fish Vaccine Industry Restraints
3 Fish Vaccine Market by Company
- 3.1 Global Fish Vaccine Company Revenue Ranking in 2025
- 3.2 Global Fish Vaccine Revenue by Company (2021-2026)
- 3.3 Global Fish Vaccine Sales Volume by Company (2021-2026)
- 3.4 Global Fish Vaccine Average Price by Company (2021-2026)
- 3.5 Global Fish Vaccine Company Ranking (2024-2026)
- 3.6 Global Fish Vaccine Company Manufacturing Base and Headquarters
- 3.7 Global Fish Vaccine Company Product Type and Application
- 3.8 Global Fish Vaccine Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Fish Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Fish Vaccine Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Fish Vaccine Market by Type
- 4.1 Fish Vaccine Type Introduction
- 4.1.1 Injectable Vaccines
- 4.1.2 Dip Vaccines
- 4.1.3 Oral Vaccine
- 4.2 Global Fish Vaccine Sales Volume by Type
- 4.2.1 Global Fish Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Fish Vaccine Sales Volume by Type (2021-2032)
- 4.2.3 Global Fish Vaccine Sales Volume Share by Type (2021-2032)
- 4.3 Global Fish Vaccine Sales Value by Type
- 4.3.1 Global Fish Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Fish Vaccine Sales Value by Type (2021-2032)
- 4.3.3 Global Fish Vaccine Sales Value Share by Type (2021-2032)
5 Fish Vaccine Market by Application
- 5.1 Fish Vaccine Application Introduction
- 5.1.1 Pangasius
- 5.1.2 Tilapia
- 5.1.3 Salmon
- 5.1.4 Seabass
- 5.1.5 Others
- 5.2 Global Fish Vaccine Sales Volume by Application
- 5.2.1 Global Fish Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Fish Vaccine Sales Volume by Application (2021-2032)
- 5.2.3 Global Fish Vaccine Sales Volume Share by Application (2021-2032)
- 5.3 Global Fish Vaccine Sales Value by Application
- 5.3.1 Global Fish Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Fish Vaccine Sales Value by Application (2021-2032)
- 5.3.3 Global Fish Vaccine Sales Value Share by Application (2021-2032)
6 Fish Vaccine Regional Sales and Value Analysis
- 6.1 Global Fish Vaccine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Fish Vaccine Sales by Region (2021-2032)
- 6.2.1 Global Fish Vaccine Sales by Region: 2021-2026
- 6.2.2 Global Fish Vaccine Sales by Region (2027-2032)
- 6.3 Global Fish Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Fish Vaccine Sales Value by Region (2021-2032)
- 6.4.1 Global Fish Vaccine Sales Value by Region: 2021-2026
- 6.4.2 Global Fish Vaccine Sales Value by Region (2027-2032)
- 6.5 Global Fish Vaccine Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Fish Vaccine Sales Value (2021-2032)
- 6.6.2 North America Fish Vaccine Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Fish Vaccine Sales Value (2021-2032)
- 6.7.2 Europe Fish Vaccine Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Fish Vaccine Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Fish Vaccine Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Fish Vaccine Sales Value (2021-2032)
- 6.9.2 South America Fish Vaccine Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Fish Vaccine Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Fish Vaccine Sales Value Share by Country, 2025 VS 2032
7 Fish Vaccine Country-level Sales and Value Analysis
- 7.1 Global Fish Vaccine Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Fish Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Fish Vaccine Sales by Country (2021-2032)
- 7.3.1 Global Fish Vaccine Sales by Country (2021-2026)
- 7.3.2 Global Fish Vaccine Sales by Country (2027-2032)
- 7.4 Global Fish Vaccine Sales Value by Country (2021-2032)
- 7.4.1 Global Fish Vaccine Sales Value by Country (2021-2026)
- 7.4.2 Global Fish Vaccine Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.9.2 France Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.16.2 China Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.19.2 India Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Fish Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Fish Vaccine Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Fish Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Fish Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Zoetis
- 8.1.1 Zoetis Company Information
- 8.1.2 Zoetis Business Overview
- 8.1.3 Zoetis Fish Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Zoetis Fish Vaccine Product Portfolio
- 8.1.5 Zoetis Recent Developments
- 8.2 Merck & Co., Inc.
- 8.2.1 Merck & Co., Inc. Company Information
- 8.2.2 Merck & Co., Inc. Business Overview
- 8.2.3 Merck & Co., Inc. Fish Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Merck & Co., Inc. Fish Vaccine Product Portfolio
- 8.2.5 Merck & Co., Inc. Recent Developments
- 8.3 Tecnovax
- 8.3.1 Tecnovax Company Information
- 8.3.2 Tecnovax Business Overview
- 8.3.3 Tecnovax Fish Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Tecnovax Fish Vaccine Product Portfolio
- 8.3.5 Tecnovax Recent Developments
- 8.4 Veterquimica S.A.
- 8.4.1 Veterquimica S.A. Company Information
- 8.4.2 Veterquimica S.A. Business Overview
- 8.4.3 Veterquimica S.A. Fish Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Veterquimica S.A. Fish Vaccine Product Portfolio
- 8.4.5 Veterquimica S.A. Recent Developments
- 8.5 HIPRA
- 8.5.1 HIPRA Company Information
- 8.5.2 HIPRA Business Overview
- 8.5.3 HIPRA Fish Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.5.4 HIPRA Fish Vaccine Product Portfolio
- 8.5.5 HIPRA Recent Developments
- 8.6 Anicon Labor GmbH
- 8.6.1 Anicon Labor GmbH Company Information
- 8.6.2 Anicon Labor GmbH Business Overview
- 8.6.3 Anicon Labor GmbH Fish Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Anicon Labor GmbH Fish Vaccine Product Portfolio
- 8.6.5 Anicon Labor GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Fish Vaccine Value Chain Analysis
- 9.1.1 Fish Vaccine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Fish Vaccine Sales Mode & Process
- 9.2 Fish Vaccine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Fish Vaccine Distributors
- 9.2.3 Fish Vaccine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst